2-[1-(4-氯苯甲酰基)-5-甲氧基-2-甲基-1H-吲哚-3-基]-1-(4-吗啉基)乙酮;
2-(1-(4-Chlorobenzoyl)-5-methoxy-2-methyl-1H-indol-3-yl)-1-morpholinoethanone; Indomethacin morpholinamide; Lopac-I-151; BML-190; 2-[1-(4-Chlorobenzoyl)-5-methoxy-2-methyl-1H-indol-3-yl]-1-(morpholin-4-yl)ethanone; Ethanone (2-[1-(4-chlorobenzoyl)-5-methoxy-2-methyl-1H-indol-3-yl]-1-(4-morpholinyl); Tocris-1383; 2-Methyl-5-methoxy-3-indolyl-essigsaeure-amid; IMMA; Indomethacin morpholinylamide; Ethanone, 2-[1-(4-chlorobenzoyl)-5-methoxy-2-methyl-1H-indol-3-yl]-1-(4-morpholinyl)-; 2-[1-(4-Chlorobenzoyl)-5-methoxy-2-methyl-1H-indol-3-yl]-1-(4-morpholinyl)ethanone; (4-chlorophenyl)[5-methoxy-2-methyl-3-(2-morpholin-4-yl-2-oxoethyl)-2H-indol-2-yl]methanone
2-8°C
DMSO: >20mg/mL
PDF: 2854-32-2_ch
PDF: 2854-32-2_en